Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447934 · ClinicalTrials.gov registry record · NA
Trial to Test the Effectiveness of Vibrotactile Stimulation for Lower Limb Spasticity
A NA study, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07447934: Recruiting NA study, sponsored by Weill Medical College of Cornell University.
NCT07447934 is a NA study that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07447934, a NA study, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to find out if Vibrotactile Stimulation (VTS) can help improve mobility and reduce spasticity (muscle stiffness) in people with lower limb spasticity. The study will also look at how VTS affects walking speed. The main questions it aims to answer are: * Which areas of the body are the best for applying VTS? * Does VTS help improve walking speed in people with lower limb spasticity? Participants will: * Receive 15 minutes of VTS treatment on different parts of the body * Use the VTS device for 60 minutes during supervised lab sessions and at home (at rest and while walking) * Complete a daily log of how much time the device was used for and note any issues or difficulties the participant experience * Complete assessments after the treatment to measure change in mobility * Complete surveys about how comfortable the device is to use
Primary Outcome
Assesses spinal reflex excitability as a neurophysiological indicator of spasticity modulation. μV amplitude; no fixed range.
Interventions
- DEVICE Vibrotactile Stimulation (Static Use)
- DEVICE Vibrotactile Stimulation (Dynamic Use)
- DEVICE Vibrotactile Stimulation (Neurophysiological Mechanism)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-04-30 |
| Est. Completion | 2027-10-31 |
| Phase | NA |
What NCT07447934 shows while recruiting
NCT07447934 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Vibrotactile Stimulation (Static Use) is the first listed.
NCT07447934 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07447934 about?
NCT07447934 is a clinical study titled "Trial to Test the Effectiveness of Vibrotactile Stimulation for Lower Limb Spasticity". The goal of this clinical trial is to find out if Vibrotactile Stimulation (VTS) can help improve mobility and reduce spasticity (muscle stiffness) in people with lower limb spasticity. The study will also look at how VTS affects walking speed. The main questions it aims to answer are: * Which area...
What is the current status of trial NCT07447934?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-04-30. Estimated completion is 2027-10-31.
What interventions are being tested in trial NCT07447934?
The interventions under investigation include: Vibrotactile Stimulation (Static Use) (DEVICE), Vibrotactile Stimulation (Dynamic Use) (DEVICE), Vibrotactile Stimulation (Neurophysiological Mechanism) (DEVICE).
Who is sponsoring clinical trial NCT07447934?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07447934's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI